Skip to content

Thursday, April 25, 2024

Latest:

Patient’s leg saved by Baylor Medicine surgeon
Understanding the neural dynamics of emotional processing in treatment-resistant depression
Prevent trouble with your tattoo
Your foot hurts. What do you do now?
When medicine becomes political

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

epigenetic chromatin remodeling

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A, cancer resistance to therapy, cisplatin, DNA repair, epigenetic chromatin remodeling, panobinostat, Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

From the Labs Image of the Month:

From the Labs: Human retinal organoid.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951